Velasco F - Search Results

1

Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.

Barbarroja N, Torres LA, Luque MJ, Carretero RM, Valverde-Estepa A, Lopez-Sanchez LM, Rodriguez-Ariza A, Velasco F, Torres A, López-Pedrera C. Barbarroja N, et al. Among authors: velasco f. Exp Hematol. 2009 Jun;37(6):679-91. doi: 10.1016/j.exphem.2009.03.001. Exp Hematol. 2009. PMID: 19463770 Free article.

2

Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.

Velasco F, Torres A, Rojas R, Alvarez MA, Gomez P, Castillo D. Velasco F, et al. Haemostasis. 1992;22(3):117-23. doi: 10.1159/000216306. Haemostasis. 1992. PMID: 1427455

3

Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation.

Torres A, Martinez F, Gomez P, Herrera C, Rojas R, Gomez-Villagran JL, Garcia-Castellano JM, Velasco F, Andres P, Fornes G, et al. Torres A, et al. Among authors: velasco f. Blut. 1989 Feb;58(2):63-8. doi: 10.1007/BF00320650. Blut. 1989. PMID: 2645954 Clinical Trial.

4

Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.

Velasco F, Torres A, Andres P, Martinez F, Gomez P. Velasco F, et al. Thromb Haemost. 1984 Aug 31;52(1):81-4. Thromb Haemost. 1984. PMID: 6238445

5

Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock.

Roman J, Velasco F, Fernandez F, Fernandez M, Villalba R, Rubio V, Vicente A, Torres A. Roman J, et al. Among authors: velasco f. Haemostasis. 1993 May-Jun;23(3):142-8. doi: 10.1159/000216867. Haemostasis. 1993. PMID: 8276317

6

Serum TNF levels in neonatal sepsis and septic shock.

Roman J, Fernandez F, Velasco F, Rojas R, Roldan MR, Torres A. Roman J, et al. Among authors: velasco f. Acta Paediatr. 1993 Apr;82(4):352-4. doi: 10.1111/j.1651-2227.1993.tb12695.x. Acta Paediatr. 1993. PMID: 8318801

7

Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.

Martin-Malo A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P. Martin-Malo A, et al. Among authors: velasco f. Kidney Int Suppl. 1993 Jun;41:S213-6. Kidney Int Suppl. 1993. PMID: 8320924 Clinical Trial.

8

Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.

Guerrero R, Velasco F, Rodriguez M, Lopez A, Rojas R, Alvarez MA, Villalba R, Rubio V, Torres A, del Castillo D. Guerrero R, et al. Among authors: velasco f. J Clin Invest. 1993 Jun;91(6):2754-60. doi: 10.1172/JCI116516. J Clin Invest. 1993. PMID: 8514883 Free PMC article.

9

Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment.

Sánchez J, Velasco F, Alvarez R, Román J, Torres A. Sánchez J, et al. Among authors: velasco f. Acta Paediatr. 1996 Feb;85(2):245-7. doi: 10.1111/j.1651-2227.1996.tb14003.x. Acta Paediatr. 1996. PMID: 8640060

10

Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.

Jardí M, Inglés-Esteve J, Burgal M, Azqueta C, Velasco F, López-Pedrera C, Miles LA, Félez J. Jardí M, et al. Among authors: velasco f. Thromb Haemost. 1996 Dec;76(6):1009-19. Thromb Haemost. 1996. PMID: 8972026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters